155 related articles for article (PubMed ID: 30328580)
1. Histone Deacetylase 3 Inhibitor Suppresses Hepatitis C Virus Replication by Regulating Apo-A1 and LEAP-1 Expression.
Zhou Y; Wang Q; Yang Q; Tang J; Xu C; Gai D; Chen X; Chen J
Virol Sin; 2018 Oct; 33(5):418-428. PubMed ID: 30328580
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effect of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) on hepatitis C virus replication.
Sato A; Saito Y; Sugiyama K; Sakasegawa N; Muramatsu T; Fukuda S; Yoneya M; Kimura M; Ebinuma H; Hibi T; Ikeda M; Kato N; Saito H
J Cell Biochem; 2013 Sep; 114(9):1987-96. PubMed ID: 23519646
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity.
Miura K; Taura K; Kodama Y; Schnabl B; Brenner DA
Hepatology; 2008 Nov; 48(5):1420-9. PubMed ID: 18671304
[TBL] [Abstract][Full Text] [Related]
4. [How Histone Deacetylase 3 Controls Hepcidin Expression and Hepatitis C Virus Replication].
Shcherbakova AS; Kochetkov SN; Kozlov MV
Mol Biol (Mosk); 2023; 57(3):427-439. PubMed ID: 37326046
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes.
Kozlov MV; Kleymenova AA; Konduktorov KA; Malikova AZ; Kochetkov SN
Biochemistry (Mosc); 2014 Jul; 79(7):637-42. PubMed ID: 25108326
[TBL] [Abstract][Full Text] [Related]
6. A Small Molecule, 4-Phenylbutyric Acid, Suppresses HCV Replication via Epigenetically Induced Hepatic Hepcidin.
Kim K; Lee YS; Jeong S; Kim D; Chon S; Pak YK; Kim S; Ha J; Kang I; Choe W
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752233
[TBL] [Abstract][Full Text] [Related]
7. Hydroxamic acids block replication of hepatitis C virus.
Ai T; Xu Y; Qiu L; Geraghty RJ; Chen L
J Med Chem; 2015 Jan; 58(2):785-800. PubMed ID: 25490700
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of BRM/SMARCA2 sensitizes clear cell renal cell carcinoma to histone deacetylase complex inhibitors.
Fang R; Pan R; Wang X; Liang Y; Wang X; Ma H; Zhou X; Xia Q; Rao Q
Pathol Res Pract; 2020 Apr; 216(4):152867. PubMed ID: 32067803
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
10. Autotaxin-lysophosphatidic acid receptor signalling regulates hepatitis C virus replication.
Farquhar MJ; Humphreys IS; Rudge SA; Wilson GK; Bhattacharya B; Ciaccia M; Hu K; Zhang Q; Mailly L; Reynolds GM; Ashcroft M; Balfe P; Baumert TF; Roessler S; Wakelam MJO; McKeating JA
J Hepatol; 2017 May; 66(5):919-929. PubMed ID: 28126468
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma.
Lu YS; Kashida Y; Kulp SK; Wang YC; Wang D; Hung JH; Tang M; Lin ZZ; Chen TJ; Cheng AL; Chen CS
Hepatology; 2007 Oct; 46(4):1119-30. PubMed ID: 17654699
[TBL] [Abstract][Full Text] [Related]
12. Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
McLeod AB; Stice JP; Wardell SE; Alley HM; Chang CY; McDonnell DP
Prostate; 2018 Mar; 78(4):266-277. PubMed ID: 29243324
[TBL] [Abstract][Full Text] [Related]
13. The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice.
Jia H; Wang Y; Morris CD; Jacques V; Gottesfeld JM; Rusche JR; Thomas EA
PLoS One; 2016; 11(3):e0152498. PubMed ID: 27031333
[TBL] [Abstract][Full Text] [Related]
14. Differential association of STAT3 and HK-II expression in hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma.
Li M; Wang W; Jin R; Zhang T; Li N; Han Q; Wei P; Liu Z
J Med Virol; 2016 Sep; 88(9):1552-9. PubMed ID: 26889748
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase 3 promotes liver regeneration and liver cancer cells proliferation through signal transducer and activator of transcription 3 signaling pathway.
Lu XF; Cao XY; Zhu YJ; Wu ZR; Zhuang X; Shao MY; Xu Q; Zhou YJ; Ji HJ; Lu QR; Shi YJ; Zeng Y; Bu H
Cell Death Dis; 2018 Mar; 9(3):398. PubMed ID: 29540666
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of N'-propylhydrazide analogs of hydroxamic inhibitors of histone deacetylases (HDACs) and evaluation of their impact on activities of HDACs and replication of hepatitis C virus (HCV).
Kozlov MV; Konduktorov KA; Shcherbakova AS; Kochetkov SN
Bioorg Med Chem Lett; 2019 Aug; 29(16):2369-2374. PubMed ID: 31201063
[TBL] [Abstract][Full Text] [Related]
17. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN
J Virol; 2015 Aug; 89(15):7905-21. PubMed ID: 25995247
[TBL] [Abstract][Full Text] [Related]
18. The Bdnf and Npas4 genes are targets of HDAC3-mediated transcriptional repression.
Louis Sam Titus ASC; Sharma D; Kim MS; D'Mello SR
BMC Neurosci; 2019 Dec; 20(1):65. PubMed ID: 31883511
[TBL] [Abstract][Full Text] [Related]
19. Structural isomers of cinnamic hydroxamic acids block HCV replication via different mechanisms.
Kozlov MV; Konduktorov KA; Malikova AZ; Kamarova KA; Shcherbakova AS; Solyev PN; Kochetkov SN
Eur J Med Chem; 2019 Dec; 183():111723. PubMed ID: 31557613
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
